Immunological biomarkers: Catalysts for translational advances in autoimmune diabetes

Clinical and Experimental Immunology

Volumn 172, Issue 2, 2013, Pages 178-185

  Ahmed, S T ^a   Akirav, E ^b   Bradshaw, E ^c   Buckner, J ^d   Mckinney, E ^e   Quintana, F J ^c   Waldron Lynch, F ^e   Nepom, J ^d  

^a JDRF   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BENAROYA RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Autoimmunity; Diabetes; Peptide immunotherapy

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CYTOKINE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CATALYST; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; DATA BASE; DISEASE COURSE; DNA METHYLATION; ENZYME LINKED IMMUNOSPOT ASSAY; EPIGENETICS; GENETIC RISK; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

AUTOIMMUNITY; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; HUMANS; T-LYMPHOCYTES;

EID: 84876086248     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12063     Document Type: Article

References (40)

1. Roep BO, Peakman M. Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes. Nat Rev Immunol 2010; 10:145-152.
2. Carey C, Purohit S, She JX. Advances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologies. Expert Opin Med Diagn 2010; 4:397-410.
3. Roep BO, Buckner J, Sawcer S, Toes R, Zipp F. The problems and promises of research into human immunology and autoimmune disease. Nat Med 2012; 18:48-53.
4. van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011; 91:79-118.
5. Gaglia JL, Guimaraes AR, Harisinghani M etal. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest 2011; 121:442-445.
6. Rowe PA, Campbell-Thompson ML, Schatz DA, Atkinson MA. The pancreas in human type 1 diabetes. Semin Immunopathol 2011; 33:29-43.
7. Bulek AM, Cole DK, Skowera A etal. Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes. Nat Immunol 2012; 13:283-289.
8. Nepom GT. MHC class II tetramers. J Immunol 2012; 188:2477-2482.
9. Herold KC, Brooks-Worrell B, Palmer J etal., Type 1 Diabetes TrialNet Research Group. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. Diabetes 2009; 58:2588-2595.
10. Crawford F, Stadinski B, Jin N etal. Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse. Proc Natl Acad Sci USA 2011; 108:16729-16734.
11. Velthuis JH, Unger WW, Abreu JR etal. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 2010; 59:1721-1730.
12. Abreu JR, Martina S, Verrijn Stuart AA etal. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clin Exp Immunol 2012; 170:57-65.
13. Robins H, Desmarais C, Matthis J etal. Ultra-sensitive detection of rare T cell clones. J Immunol Methods 2012; 375:14-19.
14. Long SA, Cerosaletti K, Bollyky PL etal. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes 2010; 59:407-415.
15. Cao T, Ueno H, Glaser C, Fay JW, Palucka AK, Banchereau J. Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL. Eur J Immunol 2007; 37:2657-2667.
16. Levy H, Wang X, Kaldunski M etal. Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes. Genes Immun 2012; 13:593-604.
17. McKinney EF, Lyons PA, Carr EJ etal. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 2010; 16:586-591, 1 p following 91.
18. Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 2007; 92:3705-3711.
19. Qiu J, LaBaer J. Nucleic acid programmable protein array a just-in-time multiplexed protein expression and purification platform. Methods Enzymol 2011; 500:151-163.
20. Akirav EM, Lebastchi J, Galvan EM etal. Detection of beta cell death in diabetes using differentially methylated circulating DNA. Proc Natl Acad Sci USA 2011; 108:19018-19023.
21. O'Neill SK, Liu E, Cambier JC. Change you can B(cell)eive in: recent progress confirms a critical role for B cells in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2009; 16:293-298.
22. Bradshaw EM, Kent SC, Tripuraneni V etal. Concurrent detection of secreted products from human lymphocytes by microengraving: cytokines and antigen-reactive antibodies. Clin Immunol 2008; 129:10-18.
23. Bradshaw EM, Raddassi K, Elyaman W etal. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol 2009; 183:4432-4439.
24. Burger DE, Wang L, Ban L etal. Novel automated blood separations validate whole cell biomarkers. PLoS One 2011; 6:e22430.
25. Newell EW, Sigal N, Bendall SC, Nolan GP, Davis MM. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 2012; 36:142-152.
26. Sevinsky JR, Cargile BJ, Bunger MK etal. Whole genome searching with shotgun proteomic data: applications for genome annotation. J Proteome Res 2008; 7:80-88.
27. Paweletz CP, Wiener MC, Bondarenko AY etal. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry. J Proteome Res 2010; 9:1392-1401.
28. Wang TJ, Larson MG, Vasan RS etal. Metabolite profiles and the risk of developing diabetes. Nat Med 2011; 17:448-453.
29. Zhi W, Sharma A, Purohit S etal. Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays. Mol Cell Proteomics 2011; 10:M111012203.
30. Tiberti C, Yu L, Lucantoni F etal. Detection of four diabetes specific autoantibodies in a single radioimmunoassay: an innovative high-throughput approach for autoimmune diabetes screening. Clin Exp Immunol 2011; 166:317-324.
31. Hober D, Sane F, Jaidane H, Riedweg K, Goffard A, Desailloud R. Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes. Clin Exp Immunol 2012; 168:47-51.
32. Jaidane H, Sane F, Hiar R etal. Immunology in the clinic review series; focus on type 1 diabetes and viruses: enterovirus, thymus and type 1 diabetes pathogenesis. Clin Exp Immunol 2012; 168:39-46.
33. Lind K, Huhn MH, Flodstrom-Tullberg M. Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes. Clin Exp Immunol 2012; 168:30-38.
34. Grieco FA, Sebastiani G, Spagnuolo I, Patti A, Dotta F. Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function. Clin Exp Immunol 2012; 168:24-29.
35. Stene LC, Rewers M. Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies. Clin Exp Immunol 2012; 168:12-23.
36. Coppieters KT, Wiberg A, Tracy SM, von Herrath MG. Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma. Clin Exp Immunol 2012; 168:5-11.
37. Gale EA. Viruses and type 1 diabetes: ignorance acquires a better vocabulary. Clin Exp Immunol 2012; 168:1-4.
38. Han D, Cai X, Wen J etal. Innate and adaptive immune gene expression profiles as biomarkers in human type 1 diabetes. Clin Exp Immunol 2012; 170:131-138.
39. Mallone R, Mannering SI, Brooks-Worrell BM etal. Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society. Clin Exp Immunol 2011; 163:33-49.
40. Campbell-Thompson M, Wasserfall C, Kaddis J etal. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev 2012; 28:608-617.